4.6 Review

Novel effector molecules in type 2 inflammation: Lessons drawn from helminth infection and allergy

Journal

JOURNAL OF IMMUNOLOGY
Volume 177, Issue 3, Pages 1393-1399

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.177.3.1393

Keywords

-

Categories

Funding

  1. NIAID NIH HHS [AI61570, R01 AI061570] Funding Source: Medline
  2. NIDDK NIH HHS [DK50306, P30 DK050306] Funding Source: Medline

Ask authors/readers for more resources

Type 2 cytokine-induced inflammatory responses are critical components of the mucosal immune response required for host defense against helminth infection and are also responsible for the pathogenesis of many debilitating diseases including asthma, allergy, and forms of inflammatory bowel disease. Given the global prevalence of helminth infections, with an estimated two billion individuals infected worldwide, and the pandemic levels of asthma and allergy, with 30% of the population affected in North America, it is essential to define the molecules and pathways that underlie the protective or pathologic consequences of type 2 inflammation. In this review, we will focus on four families of proteins that are highly induced in helminth infection and allergy: 1) the arginases; 2) the resistin-like molecules; 3) the chitinase-like mammalian proteins; and 4) the intelectins. Here, we summarize what is known about their regulation and potential function in protecting against infection and/or exacerbating inflammation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available